PBTQ Gains, Lifted by Celgene, Genzyme Friday, October 1, 8:43 AM ET, by Market News Video Staff The PowerShares Global Biotech Portfolio (PBTQ) has a market value of only $3.7 million, but ...
Gilead Sciences 23.68% of Biotech HOLDRS ETF Thursday, October 7, 8:24 AM ET, by Market News Video Staff Gilead Sciences (GILD) makes up 23.68% of the Biotech HOLDRS (BBH) ETF. The Biotech HOLDRS ...
Genzyme Insists $69 Per Share Too Low Friday, October 22, 3:32 PM ET, by Market News Video Staff The Board of Directors for Genzyme Corp. (GENZ) continues to rebuff the hostile takeover efforts ...
IBB Sees Heavy Shorting, Largest Holding Amgen Monday, October 25, 10:08 AM ET, by Market News Video Staff There are 7,884,900 shares short of the iShares Nasdaq Biotechnology Index Fund (IBB) according to ...
In trading on Monday, shares of Gilead Sciences, Inc. (NASDAQ:GILD) crossed below their 200 day moving average of $39.90, changing hands as low as $39.72 per share. Gilead Sciences, Inc. shares are currently trading down about 1.4% on the day. The chart below shows the one year performance of GILD shares, versus its 200 day moving average:
Looking at the chart above, GILD's low point in its 52 week range is $35.28 per share, with $43.49 as the 52 week high point — that compares with a last trade of $39.86.
According to the ETF Finder at ETF Channel, GILD makes up 25.45% of the Biotech HOLDRS ETF (AMEX:BBH) which is trading lower by about 1.8% on the day Monday.
GILD operates in the Biotechnology sector, among companies like Enzon Pharmaceuticals Inc (NASDAQ:ENZN) which is down about 3.3% today, and Affymetrix, Inc. (NASDAQ:AFFX) trading lower by about 7.9%. Below is a three month price history chart comparing the stock performance of GILD, versus ENZN and AFFX.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors —
anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset
allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors,
commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow
the performance trail wherever it leads us.
This Article's Word Cloud:AFFXAMEXAverageBelowBiotechnologyChannelENZNETFsFinderFreeGILDGROWTHGileadINVESTMENTMondayNASDAQPORTFOLIOPortfolioSciencesaboutamongassetaveragebelowcashchartcompaniesdesigneddownhandshistorylowermovingoperatesotherperformancepointportfoliosharesharesslideshowstockstheretradingversusweekwhatwhichwithyear
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
Now Playing:
Learn About The 200 DMA
Start slideshow:
Weekly Market Wrap: May 18, 2012
Daily Dividend Report: MNRO, MCD, CTL, MCK, HNZ, POR
Week Ahead Market Report: May 14, 2012
Weekly Market Wrap: May 11, 2012
Walmart Announces Earnings
Daily Market Wrap: May 24, 2012
